Corpus Intelligence IC Memo — THE VILLAGES REGIONAL HOSPITAL 2026-04-26 09:31 UTC
IC Memo — THE VILLAGES REGIONAL HOSPITAL
Investment Committee Memorandum | FL | 277 beds | Grade B | EBITDA uplift $16.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

THE VILLAGES REGIONAL HOSPITAL

CCN 100290 | SUMTER, FL | 277 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

THE VILLAGES REGIONAL HOSPITAL is a 277-bed suburban community hospital in SUMTER, FL with $218.9M in net patient revenue and a 2.1% operating margin. The hospital serves a payer mix of 42.8% Medicare, 4.3% Medicaid, and 52.9% commercial.

Thesis: Undervalued. Our ML models identify $16.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.1% to 9.5% (+736bps).

Net Revenue HCRIS$218.9M
Current EBITDA COMPUTED$4.7M
Operating Margin COMPUTED2.1%
Occupancy HCRIS68.8%
Revenue / Bed COMPUTED$790K
Net-to-Gross HCRIS20.5%
Distress Probability ML44.6%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
106
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 2.1% places it below the state median. Among 106 size-comparable peers (138-554 beds), the median margin is 3.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (138-554), prioritizing same-state peers. 106 hospitals in the comp set.

HospitalStateBedsRevenueMargin
THE VILLAGES REGIONAL HOSPITAL (Target)FL277$218.9M2.1%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
MOUNT SINAI MEDICAL CENTER OF FL481$904.2M12.2%
TALLAHASSEE MEMORIAL HOSPITALFL483$871.6M-4.8%
SHANDS JACKSONVILLE MEDICAL CEFL481$861.4M-7.1%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
HCA FLORIDA OCALA HOSPITALFL509$761.7M27.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $16.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.6M+210bp18mo
Cost to Collect4.5%2.5%$4.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.7M+122bp9mo
Clean Claim Rate88.0%96.0%$140K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.6M
Cost to Collect
$4.4M
Denial Rate Reduction
$4.3M
A/R Days Reduction
$2.7M
Clean Claim Rate
$140K
Total EBITDA Uplift$16.1M
Current EBITDA$4.7M
+ RCM Uplift+$16.1M
Pro Forma EBITDA$20.8M
Current Margin2.1%
Pro Forma Margin9.5%
WC Released (1x)$8.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$7.2M$191.9M26.76x93.0%
Base (11x exit)10.0x11.0x$7.2M$213.4M29.76x97.1%
Bull Case9.0x11.0x$6.5M$268.9M41.66x110.8%
Bull (12x exit)9.0x12.0x$6.5M$295.2M45.75x114.8%
Bear Case11.0x10.0x$7.9M$109.0M13.82x69.1%
Bear (11x exit)11.0x11.0x$7.9M$122.4M15.52x73.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 106 hospitals with 138-554 beds
  • Same-state prioritization (n=107)
  • Comp margins: P25=-4.8% / P50=3.7% / P75=17.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.